Intera Atlas
Run match
Sites / Northeast Research Institute
Is this you?

Request access for Northeast Research Institute with your @nerifl.com work email. Intera will contact you to verify and set up your account — nothing auto-publishes.

Request account

Northeast Research Institute

Unclaimed profile

Site Network · Fleming Island, Florida · ~3 sites

WebsiteLinkedInRank for protocol
Intera lens
ICP 7Lift (cardio sample) 0.57Recruit soph 0.43
Quality Scorecard (1–100)
Overall89Recruit75Ops91Sponsor96Ther98

Performance (observed)

Historical trials
800
Completed
455
Terminated/Withdrawn
80
Completion rate
85%
Active now
246
Phase 2
282
Phase 3
416
Realized enrollment
839,373
First study year
1984
Years active
42
Match confidence
low (approx)
Enrollment velocity (inf)
19,985

Therapeutic

Areas
Obesity, Type 2 Diabetes, Cardiovascular disease, Diabetes, Overweight, Chronic kidney disease, Heart failure, Stroke, Myocardial infarction, Inflammation, Non-alcoholic lung cancer
Specialties
Obesity, Type 2 Diabetes, Overweight, Cardiovascular, Renal Disease, Blood Pressure, Thyroid, Inflammation
Breadth (conditions)
1,504
Languages
English + Spanish (detected)
States
Florida

Recruitment (web observed)

Trial Finder
Yes
Recruitment pages
Yes
Advertises recruitment
Yes
SEO
Moderate; listed in Veeva CTV and Clinical Trials.gov
Capability notes
Multi-site recruitment (Fleming Island, Jacksonville, and third location); enrollment across cardiometabolic and metabolic disease spaces; compensation available

Relationships

Sponsors
National Cancer Institute (NCI); Alliance for Clinical Trials in Oncology; SWOG Cancer Research Network; Radiation Therapy Oncology Group; Eli Lilly and Company; Novo Nordisk A/S
CROs
Acrotech Biopharma Inc.; IQVIA Pty Ltd; Medpace, Inc.; MicroConstants; MicroPort CRM; Premier Research
Owner / parent
Private/independently held (founded 2017)
Recent hiring
Limited evidence

Capacity & people

Investigators
—
Coordinators
—
VP Clinical Ops
Kelly Bakkar (Director of Operations)
VP Site Ops
Kelly Bakkar
Emails
unitedstates@bitrialsupport.com

Tech & DCT

eSource
Yes
Builds tech
Vendors (EDC systems)
Home visits
Y; outpatient patient-centered approach
DCT / decentralized
Y; outpatient research model across 3 Florida locations
Tech stack
Modern EDC systems capable of data transmission to sponsors; centralized regulatory and compliance infrastructure
Recruiting visible
Y

Notes

Site network with 3 Florida locations and 6 active recruiting cardiometabolic trials confirmed (ClinicalTrials.gov validation). Founded 2017; rapid growth from 1 site/1 trial to 3 sites/28+ trials within 5 years. Focus on obesity, diabetes, and cardiovascular disease aligns with high-volume cardiometabolic space. Strong operational infrastructure with centralized management. Score reflects: multi-site network, cardiometabolic specialization, growth trajectory, professional operations team; limited by younger organizational age and undefined CEO-level leadership.

Recommendation features (sample indication)

Ind fit 1.00Liftability 0.57Overall89

FUTURE MOAT: absolute enrollment rates, funnel CPR, measured SSU, screen-fail reasons.